Bleomycin sulphate 15 mg

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes biapenem*. It belongs to antibacterial ( betalactum ) apis products category. Contact us for more information.

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes bicalutamide. It belongs to antineoplastic apis category. Contact us for more information.

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes bicalutamide tablets 50 mg. It belongs toanticancer ( oral / injection) finish formulations products category. Contact us for more information.

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes bimatoprost. It belongs to antiglaucoma apis products category. Contact us for more information.

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes bivalirudin. It belongs to anticoagulant apis category. Contact us for more information.

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes bivalirudin 250 mg inj. It belongs to cardiac finish formulations products category. Contact us for more information.

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes bortezomib. It belongs to antineoplastic apis category. Contact us for more information.

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes bortezomib 2 mg/ 3.5 mg. It belongs toalyophilised injections finish formulations products category. Contact us for more information.

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes brinzolamide. It belongs to antiglaucoma apis products category. Contact us for more information.

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes buserelin acetate. It belongs to infertility apis category. Contact us for more information.

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes buserelin acetate injection (7 mg / 7 ml). It belongs to gynaecology finish formulations products category. Contact us for more information.

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes calcipotriol. It belongs to antiparathyroid & antipsoriatic apis category. Contact us for more information.

Dharmesh Shah, Chairman & Managing Director of BDR Pharmaceuticals, speaks with CPHI TV at CPHI Worldwide in Madrid.